Selected by the World Economic Forum as one of 2018’s most promising Technology Pioneers - 1928 Diagnostics is a company on a mission to save the power of antibiotics by addressing the growing and alarming problem of antimicrobial resistance. 1928 Diagnostics provides hospitals and care professionals with a digital tool to track, stop and predict outbreaks of infections caused by superbugs.

Join us in this fireside chat with Kristina Lagerstedt, CEO and Co-Founder of 1928 Diagnostics, as we discuss:

• Kristina’s entrepreneurial journey - from a researcher working with leukemia to an entrepreneur addressing one of our worlds greatest challenges
• How COVID-19 has affected 1928 Diagnostics what are Kristina's tips to navigate through current times
• What will the future hold for 1928 Diagnostics?

Dr. Kristiana Lagerstedt is a health tech entrepreneur with over 15 years of experience in clinical research at Sahlgrenska University hospital. She believes in the power of collaboration to drive ideas that create impact. In 2019, 1928 Diagnostics was one of the ten finalists in the Nordic Norrsken Award.